NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, August 1st. Investors of record on Friday, August 31st will be paid a dividend of $0.19 per share on Tuesday, September 18th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date is Thursday, August 30th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) posted its quarterly earnings data on Thursday, August, 9th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.21 by $0.01. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.23 billion. Perrigo had a return on equity of 11.92% and a net margin of 4.77%. The firm's revenue for the quarter was down 4.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.22 EPS. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Perrigo.

Perrigo updated its FY18 earnings guidance on Thursday, August, 9th. The company provided earnings per share (EPS) guidance of $4.75-4.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.21.

16 brokers have issued 1 year target prices for Perrigo's stock. Their predictions range from $67.00 to $117.00. On average, they anticipate Perrigo's share price to reach $88.6875 in the next year. This suggests a possible upside of 20.6% from the stock's current price. View Analyst Price Targets for Perrigo.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Some companies that are related to Perrigo include ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), GRIFOLS S A/S (GRFS), Merck KGaA (MKGAF), Ono Pharmaceutical (OPHLF), Nektar Therapeutics (NKTR), Genmab A/S (GNMSF), Jazz Pharmaceuticals (JAZZ) and Sarepta Therapeutics (SRPT).

Perrigo's stock is owned by a number of of institutional and retail investors. Top institutional investors include Starboard Value LP (7.34%), BlackRock Inc. (6.38%), FMR LLC (3.78%), Victory Capital Management Inc. (2.02%), Parnassus Investments CA (1.63%) and Manning & Napier Group LLC (1.07%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Millennium Management LLC, Systematic Financial Management LP, Migdal Insurance & Financial Holdings Ltd., Fisher Asset Management LLC, Manning & Napier Group LLC, Point72 Asset Management L.P. and Jane Street Group LLC. Company insiders that have sold Perrigo company stock in the last year include John Wesolowski, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Starboard Value LP, Los Angeles Capital Management & Equity Research Inc., Victory Capital Management Inc., Marshall Wace LLP, Harel Insurance Investments & Financial Services Ltd. and Menora Mivtachim Holdings LTD.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Svend Andersen and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $73.56.

Perrigo has a market capitalization of $10.07 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]